Last Updated 12 August 2022.
11 Vaccines Granted Emergency Use Listing (EUL) by WHO
-
Serum Institute of India
COVOVAX (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 5 countries
4 trials in 2 countries
Approval Source: extranet.who.int
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 39 countries
20 trials in 13 countries
Approval Source: extranet.who.int
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 87 countries
68 trials in 24 countries
Approval Source: extranet.who.int
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 147 countries
89 trials in 28 countries
Approval Source: extranet.who.int
-
CanSino
Convidecia- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 10 countries
14 trials in 6 countries
Approval Source: extranet.who.int
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 111 countries
24 trials in 24 countries
Approval Source: extranet.who.int
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 148 countries
69 trials in 32 countries
Approval Source: extranet.who.int
-
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 49 countries
4 trials in 1 country
Approval Source: extranet.who.int
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 14 countries
14 trials in 2 countries
Approval Source: extranet.who.int
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 92 countries
37 trials in 15 countries
Approval Source: extranet.who.int
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
40 trials in 10 countries
Approval Source: extranet.who.int